EBAMed
EBAMed develops external beam ablation medical devices that utilize radio-therapy for the non-invasive treatment of heart arrhythmias. This technology provides a painless alternative to traditional invasive procedures, improving patient comfort and reducing recovery time.
- Healthcare Technology
- Medical Devices
Funding
Raised to date
$21.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 4 rounds
EFEUFSMC+3€1.6M · Series A Extension
Announced Jan 2025 · from article date
Disclosed cumulative: $18.7M
Not on chart (date unknown): Grant €2.4M
Founders
Product
Problem
Traditional invasive procedures for treating heart arrhythmias can be painful and require significant recovery time. These procedures also carry inherent risks associated with surgical interventions.
Solution
EBAMed develops external beam ablation medical devices that offer a non-invasive alternative for treating heart arrhythmias using radio-therapy. This technology aims to provide a painless treatment option, potentially improving patient comfort and reducing recovery time compared to traditional invasive methods. By utilizing external beam ablation, EBAMed's devices target and ablate the problematic heart tissue without requiring surgical incisions or direct contact with the heart. This approach could lead to fewer complications and a faster return to normal activities for patients.
Target Audience
The primary target audience includes cardiologists and electrophysiologists seeking less invasive treatment options for patients with heart arrhythmias.
Features
- Non-invasive treatment of heart arrhythmias using external beam ablation
- Radio-therapy based technology
- Painless alternative to traditional invasive procedures